常山药业：肝素钠注射液获得土库曼斯坦药品注册证书

Core Viewpoint - Changshan Pharmaceutical (300255) has received a drug registration certificate for its Heparin Sodium Injection from the Turkmenistan drug regulatory authority, indicating a significant step in expanding its market presence [1] Company Summary - The Heparin Sodium Injection is primarily used for the prevention and treatment of thromboembolic diseases such as myocardial infarction, thrombophlebitis, and pulmonary embolism [1] - The drug is also indicated for disseminated intravascular coagulation (DIC) caused by various reasons, as well as for anticoagulation during procedures like dialysis, extracorporeal circulation, catheterization, and microvascular surgeries [1]